An annual award worth €200,000, recognising researchers whose scientific discoveries have had a major impact on the care of patients with cancer.

Launched in 2025, the Gustave Roussy Prize is awarded each year to a prominent figure in oncology research whose scientific breakthroughs in the fields of cancer diagnosis, treatment, or prevention have significantly improved patient care or led to a better understanding of the disease.

Nanomedicine laboratory - lab members

• Alexandre, DETAPPE, team leader
• Valeriya, DIMITROVA, lab manager

Nanomedicine laboratory - major publications

• Durand A, Gréa T, Lebeau G, Jacquot G, Tillement A, Aigle A, Thomas E, Kryza D, Taleb J, Ferrauto G, Gianolio E, Géloen A, Montembault A, Guttierez-Blanco M, Pivot X, Harlepp S, Detappe A, David L†, Lux F†, Tillement O^†. “Functionalization of chitosan with polycarboxylic macrocycle yields injectable hydrogel with pH and salts responsiveness”. Mater Today Adv, 2025.

Nanomedicine laboratory - Presentation

This team belongs to the UMR 1030 Molecular Radiotherapy and Novel Therapeutics

Our team develops new ways to diagnose and treat cancer using tiny, smart particles called nanomedicines. By combining advanced imaging and targeted therapies, we aim to detect tumors earlier and make treatments more effective and safer. Our ultimate goal is to bring these innovations quickly from the lab to the clinic, so they can directly benefit patients.

Genome dynamics and instability: major publications